130 related articles for article (PubMed ID: 9915462)
1. Fluorodeoxyglucose positron emission tomography scan of prostate cancer bone metastases with flare reaction after endocrine therapy.
Shimizu N; Masuda H; Yamanaka H; Oriuchi N; Inoue T; Endo K
J Urol; 1999 Feb; 161(2):608-9. PubMed ID: 9915462
[No Abstract] [Full Text] [Related]
2. Positive [11C]choline and negative [18F]FDG with positron emission tomography in recurrence of prostate cancer.
Picchio M; Landoni C; Messa C; Gianolli L; Matarrese M; De Cobelli F; Maschio AD; Fazio F
AJR Am J Roentgenol; 2002 Aug; 179(2):482-4. PubMed ID: 12130458
[No Abstract] [Full Text] [Related]
3. 18F-FDG PET/CT superscan in prostate cancer.
Bailly M; Besse H; Kerdraon R; Metrard G; Gauvain S
Clin Nucl Med; 2014 Oct; 39(10):912-4. PubMed ID: 24566401
[TBL] [Abstract][Full Text] [Related]
4. [Visualisation of prostate cancer liver metastases on a 99mTc-MDP bone scan].
Loaiza Góngora JL; Hervás Benito I; Bello Arques P; Vercher Conejero JL; Mateo Navarro A
Rev Esp Med Nucl; 2009; 28(2):80. PubMed ID: 19406055
[No Abstract] [Full Text] [Related]
5. The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.
Pollen JJ; Witztum KF; Ashburn WL
AJR Am J Roentgenol; 1984 Apr; 142(4):773-6. PubMed ID: 6230903
[TBL] [Abstract][Full Text] [Related]
6. Detection of solitary humeral metastasis from pancreatic adenocarcinoma with F-18 FDG PET/CT.
Kim J; Quon A; Humke E; Ford JM; Koong AC
Clin Nucl Med; 2009 May; 34(5):312-3. PubMed ID: 19387214
[No Abstract] [Full Text] [Related]
7. 99mTc-MDP bone scintigraphy and 18F-FDG positron emission tomography in lung and prostate cancer patients: different affinity between lytic and sclerotic bone metastases.
Garcia JR; Simo M; Perez G; Soler M; Lopez S; Setoain X; Lomeña F
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1714. PubMed ID: 14625662
[No Abstract] [Full Text] [Related]
8. Prostate-specific antigen-negative prostate cancer recurrence?
Froehner M; Abolmaali N; Wirth MP
Urology; 2013 Feb; 81(2):e17-8. PubMed ID: 23374851
[TBL] [Abstract][Full Text] [Related]
9. Bone metastases from poorly differentiated adenocarcinoma of the prostate diagnosed by In-111 ProstaScint (Capromab Pendetide) images with negative results of Tc-99m MDP bone scan and without significant elevation of prostate-specific antigen.
Norris S; Halkar R; Galt J; Petros J; Keller J
Clin Nucl Med; 1999 Nov; 24(11):905-7. PubMed ID: 10551485
[No Abstract] [Full Text] [Related]
10. FDG PET/CT in a Case of Pure Ductal Adenocarcinoma of the Prostate With Osteolytic Metastases and Normal PSA Level.
Dong A; Lin X; Bai Y; Yang B; Xu S
Clin Nucl Med; 2023 Jul; 48(7):640-642. PubMed ID: 36976639
[TBL] [Abstract][Full Text] [Related]
11. [A case of prostate cancer associated with osteolytic bone metastases].
Migita T; Maeda K; Ogata N
Hinyokika Kiyo; 1999 May; 45(5):371-4. PubMed ID: 10410324
[TBL] [Abstract][Full Text] [Related]
12. FDG PET/CT imaging in prostate adenocarcinoma presenting as isolated brain metastases of unknown origin.
Erhamamcı S; Reyhan M; Alkan O
Rev Esp Med Nucl Imagen Mol; 2015; 34(2):146-7. PubMed ID: 25052407
[No Abstract] [Full Text] [Related]
13. FDG PET/CT in Peritoneal Metastasis From Prostate Cancer.
Gungor S; Asa S; Kupik O
Clin Nucl Med; 2016 Sep; 41(9):e424-5. PubMed ID: 27187732
[TBL] [Abstract][Full Text] [Related]
14. F-18 FDG PET superscan.
Su HY; Liu RS; Liao SQ; Wang SJ
Clin Nucl Med; 2006 Jan; 31(1):28-9. PubMed ID: 16374120
[No Abstract] [Full Text] [Related]
15. Detection of bone metastases in cancer patients by 18F-fluoride and 18F-fluorodeoxyglucose positron emission tomography.
Cook GJ; Fogelman I
Q J Nucl Med; 2001 Mar; 45(1):47-52. PubMed ID: 11456375
[TBL] [Abstract][Full Text] [Related]
16. [Pet imaging in prostate cancer].
Oyama N; Kaneda T; Nakai M; Shioyama R; Matsuta Y; Tanase K; Aoki Y; Miwa Y; Akino H; Yokoyama O; Okazawa H; Fujibayashi Y; Yonekura Y
Hinyokika Kiyo; 2006 Jun; 52(6):503-5. PubMed ID: 16848365
[No Abstract] [Full Text] [Related]
17. Super bone scan: bone metastases of prostate cancer.
Shikino K; Ikusaka M; Hirota Y; Sato E
BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25228679
[No Abstract] [Full Text] [Related]
18. PET/CT imaging of osteoblastic bone metastases with (68)Ga-bisphosphonates: first human study.
Fellner M; Baum RP; Kubícek V; Hermann P; Lukes I; Prasad V; Rösch F
Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):834. PubMed ID: 20069291
[No Abstract] [Full Text] [Related]
19. [Utility of PET-18FDG in primary tumor site in a patient with cerebral metastases].
Suárez Fernández JP; Serna Macías JA; Domínguez Grande ML; Liaño H; Pozo MA; Maldonado Suárez A
Rev Esp Med Nucl; 2005; 24(4):253. PubMed ID: 16122410
[No Abstract] [Full Text] [Related]
20. [A case of prostatic carcinoma with osteolytic bone metastases].
Fukuoka H; Ishibashi Y; Masuda M; Gotoh A; Murai T; Kitamura H
Hinyokika Kiyo; 1988 Oct; 34(10):1805-9. PubMed ID: 3245528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
